Strategic Growth Avalere Health operates as a global commercialization partner across biopharma, medical technology, and wellness sectors with expanding services from advisory to performance. This presents opportunities to upsell integrated solutions spanning consulting, policy, access, value evidence, marketing, and digital experience technology to clients seeking end-to-end lifecycle support.

Recognition & Awards Recent PMi award wins including Agency of the Year and multiple Golds highlight market leadership and credibility. Leverage these accolades in outreach to prospective clients seeking proven impact and industry recognition to de-risk engagements.

Productivity & Tech Skysis rebrand to Avalere Health emphasizes a broad tech stack (SAS, Tableau, AWS, OpenAI, Adobe Experience Cloud, Tealium, Hootsuite, Microsoft Teams) enabling data-driven marketing, analytics, and digital experiences. Position as a partner capable of delivering advanced analytics, AI-enabled insights, and integrated marketing operations for faster time-to-value.

New Market Expansion Recent expansions include strategic offerings targeting Japanese biopharma and data parsing for 340B analyses, plus collaborations with healthcare organizations like National Grange. These moves indicate openness to enter or deepen partnerships in new regions and data-driven reimbursement/market access services, presenting cross-sell opportunities to global manufacturers and payers.

Financial Profile Revenue in the $1M–$10M range with a lean employee base (11-50) suggests opportunities for scalable, high-margin engagements, possibly through retainer-based advisory, managed services, and value-based pricing. Target mid-sized biopharma and medtech clients seeking cost-effective, outcomes-focused commercialization support.